Zhu, Huiping <br/><br/>
Resveratrol reverts Streptozotocin-induced diabetic nephropathy.  [electronic resource] 

 -  Frontiers in bioscience (Landmark edition)  01 2020 
 - 699-709 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2768-6698 
<br/><br/><label>Standard No.: </label>10.2741/4829  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--pharmacology<br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Autophagy-Related Protein-1 Homolog--metabolism<br/>Diabetic Nephropathies--chemically induced<br/>Kidney--drug effects<br/>Lipids--analysis<br/>Male<br/>Nephrons--drug effects<br/>Organ Size--drug effects<br/>PPAR alpha--metabolism<br/>Rats, Sprague-Dawley<br/>Resveratrol--pharmacology<br/>Sterol Regulatory Element Binding Protein 1--metabolism<br/>Streptozocin<br/>TOR Serine-Threonine Kinases--metabolism